Avid Radiopharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Avid Radiopharmaceuticals's estimated annual revenue is currently $27.9M per year.
- Avid Radiopharmaceuticals's estimated revenue per employee is $201,000
- Avid Radiopharmaceuticals's total funding is $69.9M.
Employee Data
- Avid Radiopharmaceuticals has 139 Employees.
- Avid Radiopharmaceuticals grew their employee count by -1% last year.
Avid Radiopharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer, Global Imaging | Reveal Email/Phone |
2 | Associate VP, Regulatory Affairs, Imaging Medical R&D | Reveal Email/Phone |
3 | VP, Clinical Development | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | Associate VP, Quality Assurance | Reveal Email/Phone |
6 | Senior Director, Radiochemistry and Radiopharmaceutical Development | Reveal Email/Phone |
7 | Associate Director, PET Analysis and Image Management | Reveal Email/Phone |
8 | Associate Director Technical Operations | Reveal Email/Phone |
9 | Associate Director Quality Engineering | Reveal Email/Phone |
10 | Director - Clinical Imaging Scientist | Reveal Email/Phone |
Avid Radiopharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.6M | 232 | 8% | N/A | N/A |
#2 | $84.2M | 419 | 3% | N/A | N/A |
#3 | $14.1M | 70 | 0% | N/A | N/A |
#4 | $1224.3M | 6091 | -9% | N/A | N/A |
#5 | $43.2M | 215 | -4% | N/A | N/A |
#6 | $12.3M | 61 | -6% | N/A | N/A |
#7 | $19.9M | 99 | 41% | N/A | N/A |
#8 | $16.5M | 82 | -5% | N/A | N/A |
#9 | $97.7M | 486 | 30% | N/A | N/A |
#10 | $12.5M | 62 | -16% | N/A | N/A |
What Is Avid Radiopharmaceuticals?
Avid Radiopharmaceuticals, Inc. (Avid RP) is a product-focused molecular imaging company developing novel diagnostic agents to enable early diagnosis, treatment selection and therapeutic monitoring of serious diseases. The company is a pioneer in clinical development of agents for detecting and monitoring Alzheimer's disease, and its lead radiolabeled compounds are being developed to enable physicians to diagnose Alzheimer's in real-time and to allow Alzheimer's researchers to evaluate the many drug candidates targeting amyloid plaque build-up. Avid's technology can be used with a variety of imaging technologies such as PET and SPECT scanning and has already been tested in pilot human studies.
keywords:N/A
$69.9M
Total Funding
139
Number of Employees
$27.9M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avid Radiopharmaceuticals News
She participates as a site investigator in clinical trials sponsored by Avid Radiopharmaceuticals, Eli Lilly, Biogen, Eisai, Jaansen,...
... Amarantus Bioscience Holdings, Anavex LifeSciences, Avid Radiopharmaceuticals, Axon Neuroscience, Axovant Sciences, Daiichi Sankyo Co,...
... PhD, vice president of clinical development at Avid Radiopharmaceuticals, the biomarker arm of Lilly, told Medscape Medical News.
Avid Radiopharmaceuticals, a Philadelphia-based maker of “molecular imaging agents” that help highlight diseased tissue in various medical scans, raised $26 million in a third round to develop early-detection products for Alzheimer’s and Parkinson’s disease. AllianceBernstein and Safeguard Scie ...
Other Companies in Philadelphia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $37.5M | 139 | 22% | N/A |
#2 | $13.9M | 139 | 1% | N/A |
#3 | $13.9M | 139 | 6% | N/A |
#4 | $37.5M | 139 | 7% | N/A |
#5 | $37.5M | 139 | -4% | N/A |